The site selection process is complicated by outdated data, limited operational insight, and overreliance on reputation. Discover some practical ways to evaluate site feasibility for your next trial.
- Heading For An M&A? Understand The Risks And Mitigation Strategies For Clinical Trial Agreements
- Sites Are 3X Likely To Die In The First Year Than New Businesses
- Sponsors Collect Too Much "Non-Essential" Data, Say Tufts And TransCelerate
- Two Former FDA Chiefs, Two Very Different Warnings
- Global Implications Of Zero Tariffs On Indian Pharma Exports To China
- Participant Recruitment In LMIC Clinical Trials
- Behavior Modeling Can Help Sponsors Better Understand Sites And Patients
GUEST COLUMNISTS
-
![Human mind, experience diversity, personality characteristics-GettyImages-2203518410]( "Behavior Modeling Can Help Sponsors Better Understand Sites And Patients")
Behavior Modeling Can Help Sponsors Better Understand Sites And PatientsLearn how behavioral modeling can identify patients at risk of dropout and sites that may need additional support, so you can build a more resilient research network.
-
![China and united states flag-GettyImages-1089423344]( "How The U.S. Can Beat China In Biotech")
How The U.S. Can Beat China In BiotechLumen Bioscience's Brian Finrow breaks down China's biotech playbook and explores ways the U.S. can adapt it for its own continued success.
-
![Businesswoman walking in crowd-GettyImages-2208884463]( "How AI Is Transforming Patient Stratification")
How AI Is Transforming Patient StratificationDiscover how AI tools can help stratify or group patients into subtypes that respond differently to treatment.
-
![colorful arrows pointing up-GettyImages-2152056193]( "The Rise Of Specialist CROs In Clinical Outsourcing")
The Rise Of Specialist CROs In Clinical OutsourcingUnderstand the trends behind the growing specialist CRO sector.
-
![Online documentation database, AI, artificial intelligence, dms, GettyImages-2078225287]( "How AI Is Rewriting The Future Of TMF And Clinical Quality")
How AI Is Rewriting The Future Of TMF And Clinical QualityDiscover how AI is transforming the TMF from a reactive repository into a proactive, intelligent co-pilot for clinical trials.
-
![beroe_raredisease3-gettyimages-1629549075]( "Trends In Rare Disease Trials: Recommendations")
Trends In Rare Disease Trials: RecommendationsIn the third article of this series, analyst reveal their top 6 recommendations for designing selection criteria and selecting solution options to optimize rare disease research outcomes.
-
![Senior man at clinic reception desk-GettyImages-2174582061]( "The Hidden Power Of Specialized Community Research Sites In Accelerating Clinical Trials")
The Hidden Power Of Specialized Community Research Sites In Accelerating Clinical TrialsTyler Research Institute founder G. Aaron DuVall explores how community sites can offer access to diverse patient populations and build processes tailored for chronic disease care to accelerate timelines and improve outcomes.
-
![Career Path-GettyImages-2239749438]( "Regulatory Pathways — With Real-Life Examples — For Successful CGT Clinical Trials")
Regulatory Pathways — With Real-Life Examples — For Successful CGT Clinical TrialsDiscover the most effective regulatory pathways used to support CGT development, including two real-life examples.
CLINICAL TRIAL WHITE PAPERS
-
![Woman using cell phone 1263380081]( "Still Using Paper Diaries To Capture PRO Data? Read This.")
Still Using Paper Diaries To Capture PRO Data? Read This.Access real-world examples of how electronic patient-reported outcome measures (PROMs) optimize data quality and reliability and improve the statistical power of trial data.
-
A Guide To Digital Endpoints In Major Depressive Disorder3/7/2025
The integration of digital health technologies (DHTs) in clinical trials for Major Depressive Disorder (MDD) is transforming how symptom severity and treatment efficacy are measured.
-
Deal-Making Volume Slowed In 20235/15/2024
This report provides an overview of alliance, merger and acquisition, and financing deal activities across the global biopharma, medical device, and in vitro diagnostics industries in 2023, as reported by Biomedtracker.
-
Patient-Reported Outcome In Oncology Clinical Trials4/17/2025
As cancer therapies grow more complex and personalized, patient-reported outcomes (PROs) have emerged as a vital component of oncology research and care.
-
Elevating Patient Centricity In Clinical Trials2/17/2025
How can the integration of patient perspectives throughout the clinical trial process enhance engagement and outcomes?
-
Demanding More From AI Governance In Drug Safety8/13/2025
Embedding AI governance into your an AI-enabled safety system from the start empowers trust and streamlines the path toward success; it is merely the evolution of good data and risk governance.
CLINICAL TRIAL APP NOTES & CASE STUDIES
-
Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial1/16/2024
Uncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.
-
Advancing Rare Disease Clinical Trials With Point-Of-Need Eye Assessments1/29/2025
During the COVID-19 pandemic, Applied Genetic Technologies Corporation (AGTC) faced significant hurdles in enrolling participants due to travel restrictions and site limitations.
-
Optimizing Kitting For Cell Therapy Trials In Pediatric Oncology5/2/2025
Precision for Medicine’s Kitting team played a crucial role in overcoming this challenges of a Phase I multicenter pediatric cell therapy trial targeting relapsed or refractory solid tumors.
-
Addressing A Global Health Priority In Australia And New Zealand11/7/2025
For sponsors navigating a competitive therapeutic landscape, this case underscores how regional execution excellence can accelerate global impact.
-
Biotech Delivers A Superior Patient And Site Experience3/4/2025
To become the sponsor of choice for sites and patients in congenital hyperinsulinism clinical trials, a small biotech company prioritized delivering a superior experience while streamlining operations.
-
Accelerate Your Oncology Breakthroughs4/16/2025
Finding the right partnership can help your oncology clinical trials overcome trial complexities through strategic planning, a deep scientific understanding, and operational excellence.
NEWSLETTER ARCHIVE
- 11.14.25 -- Why CRA Proficiency Needs A Boost From Better Assessment And Training
- 11.14.25 -- Less Workload, More Patient Time: Elevating The Site Voice
- 11.13.25 -- The Rise Of Specialist CROs In Clinical Outsourcing
- 11.13.25 -- From Chaos To Control: Modernizing Data And Mastering Clinical Trials
- 11.12.25 -- Ask An Expert Before Shredding Your Mobile Device CAPEX
RECRUITMENT AND DIVERSITY
This section includes some helpful resources regarding patient recruitment and diversity in clinical trials, including this link to the FDA's guidance on diversity action plans.
-
![metaverse technology-GettyImages-1372364665]( "Non-Invasive Brain-Computer Interface Trial Balances Regulatory Requirements With Patient Needs")
Cognixion CTO Chris Ullrich introduces the Axon-R Nucleus bio-sensing hub and discusses its feasibility trial, highlighting the importance of patient input, caregiver quality of life, and regulatory support.
-
![community nurse with three teens-GettyImages-1442937688]( "Participant Recruitment In LMIC Clinical Trials")
Due to the high burden of infectious diseases in low- and middle-income countries (LMICs), there is greater urgency for vaccine trials. Participant recruitment entails significant work with communities.
-
![Human mind, experience diversity, personality characteristics-GettyImages-2203518410]( "Behavior Modeling Can Help Sponsors Better Understand Sites And Patients")
Learn how behavioral modeling can identify patients at risk of dropout and sites that may need additional support, so you can build a more resilient research network.
FOCUS ON PATIENTS
-
![metaverse technology-GettyImages-1372364665]( "Non-Invasive Brain-Computer Interface Trial Balances Regulatory Requirements With Patient Needs")
Cognixion CTO Chris Ullrich introduces the Axon-R Nucleus bio-sensing hub and discusses its feasibility trial, highlighting the importance of patient input, caregiver quality of life, and regulatory support.
-
![Human mind, experience diversity, personality characteristics-GettyImages-2203518410]( "Behavior Modeling Can Help Sponsors Better Understand Sites And Patients")
Learn how behavioral modeling can identify patients at risk of dropout and sites that may need additional support, so you can build a more resilient research network.
-
![sunlit brain puzzle-GettyImages-2187021354]( "How Redefining The Diagnostic Odyssey Can Lead To Better Patient Outcomes")
Patient advocate Wendy Cogan calls for improved diagnostic pathways as a means to better clinical trial recruitment and design while telling the journey of her late husband's journey to a corticobasal degeneration(CBD)-frontal behavioral-spatial syndrome (FBS) diagnosis.
